RPAM
EIGR

Rhenman & Partners Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Rhenman & Partners Asset Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
2015
Q1 		$2.27M Sell
2014
Q4 		$3.83M Sell
2014
Q3 		$2.68M Buy
2014
Q2 		$737K Buy